BrightSpring Health Services, Inc. (NASDAQ:BTSG) Q3 2025 Earnings Call October 28, 2025 4:30 PM EDT
Company Participants
Jon Rousseau – Chairman, President & CEO
Jennifer Phipps – CFO, Chief Accounting Officer & Principal Accounting Office
Conference Call Participants
David Deuchler – Gilmartin Group LLC
Albert Rice – UBS Investment Bank, Research Division
David Larsen – BTIG, LLC, Research Division
Charles Rhyee – TD Cowen, Research Division
Kieran Ryan – Deutsche Bank AG, Research Division
Brian Tanquilut – Jefferies LLC, Research Division
Ann Hynes – Mizuho Securities USA LLC, Research Division
Matthew Gillmor – KeyBanc Capital Markets Inc., Research Division
Joanna Gajuk – BofA Securities, Research Division
Erin Wilson Wright – Morgan Stanley, Research Division
Stephen Baxter – Wells Fargo Securities, LLC, Research Division
Lawrence Solow – CJS Securities, Inc.
Presentation
Operator
Good day, and thank you for standing by. Welcome to the BrightSpring Health Services Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, David Deuchler, Investor Relations. Please go ahead.
David Deuchler
Gilmartin Group LLC
Good afternoon. Thank you for participating in today’s conference call. My name is David Deuchler with Investor Relations for BrightSpring. I’m joined on today’s call by Jon Rousseau, Chief Executive Officer; and Jen Phipps, Chief Financial Officer.
Earlier today, BrightSpring released financial results for the quarter ended September 30, 2025. A copy of the press release and presentation is available on the company’s Investor Relations website.
Please note that today’s discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance and industry and market conditions. Such forward-looking statements are not guarantees of future performance. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our expectations. We encourage
